Rizamo: schedule social media posts on Instagram, TikTok, LinkedIn, Facebook, YouTube and Threads
Publish and schedule social media posts on Instagram, TikTok, LinkedIn, Facebook, YouTube and Threads with Rizamo, see how they did, and answer comments and messages. Use when the user wants to post or schedule social content, check post or account analytics, or reply to their audience.
as observed 2026-11-17T01:34:38.316Z- Identifier
rizamo- Source
- ClawHub
- Version observed
- 1.0.2
- Source repository
- not published
- Repository observation
- No source repository listed
- First observed here
- 2026-11-12T21:45:54.906Z
- Observations recorded
- 2
- Installs (reported upstream)
- 1
- Weekly downloads (upstream)
- 166
- Declared license
- MIT-0
Observation history
2026-11-17T01:34:38.316Z
Fields that differed: changelog displayName latestVersion summary topics
| Field | Before | After |
|---|---|---|
changelog |
"The API key is optional when the MCP server is connected, regular reports and checks, and OpenClaw's plugin." | "LinkedIn, live in Rizamo since 13 Nov, is now in the name and description." |
displayName |
"Rizamo: post and schedule on Instagram, TikTok, Facebook, YouTube and Threads" | "Rizamo: schedule social media posts on Instagram, TikTok, LinkedIn, Facebook, YouTube and Threads" |
latestVersion |
"1.0.1" | "1.0.2" |
summary |
"Publish and schedule social media posts on Instagram, Facebook, TikTok, YouTube and Threads with Rizamo, see how they did, and answer comments and messages. Use when the user want | "Publish and schedule social media posts on Instagram, TikTok, LinkedIn, Facebook, YouTube and Threads with Rizamo, see how they did, and answer comments and messages. Use when the |
topics |
["analytics","instagram","scheduling","social-media","tiktok"] | ["analytics","comments","inbox","scheduler","social-media"] |
Correction
If you maintain this extension and believe anything above is inaccurate, request a correction. Corrections are published, and disputed entries are marked as disputed while under review.